These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10978581)

  • 21. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells.
    Yi H; Akao Y; Maruyama W; Chen K; Shih J; Naoi M
    J Neurochem; 2006 Jan; 96(2):541-9. PubMed ID: 16336631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell death in Parkinson's disease.
    Maruyama W; Naoi M
    J Neurol; 2002 Sep; 249 Suppl 2():II6-10. PubMed ID: 12375057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative DNA damage and glioma cell death induced by tetrahydropapaveroline.
    Soh Y; Shin MH; Lee JS; Jang JH; Kim OH; Kang H; Surh YJ
    Mutat Res; 2003 Nov; 544(2-3):129-42. PubMed ID: 14644315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism.
    Storch A; Kaftan A; Burkhardt K; Schwarz J
    Brain Res; 2000 Feb; 855(1):67-75. PubMed ID: 10650131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enantio-specific induction of apoptosis by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopaminergic SH-SY5Y cells: suppression of apoptosis by N-(2-heptyl)-N-methylpropargylamine.
    Maruyama W; Boulton AA; Davis BA; Dostert P; Naoi M
    J Neural Transm (Vienna); 2001; 108(1):11-24. PubMed ID: 11261742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low level of glutathione can intensify the toxic effect of salsolinol in SH-SY5Y neuroblastoma cell line.
    Wszelaki N; Melzig MF
    Neurotoxicology; 2012 Jun; 33(3):424-8. PubMed ID: 22525935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline (1BnTIQ), an endogenous neurotoxin, induces dopaminergic cell death through apoptosis.
    Shavali S; Ebadi M
    Neurotoxicology; 2003 Jun; 24(3):417-24. PubMed ID: 12782106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the neurotoxicity of 6,7-dihydroxy-1-methyl-1,2,3,4-tetrahydroisoquinoline (salsolinol) in SH-SY5Y cells.
    Willets JM; Lambert DG; Lunec J; Griffiths HR
    Eur J Pharmacol; 1995 Dec; 293(4):319-26. PubMed ID: 8748684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
    Imamura K; Takeshima T; Kashiwaya Y; Nakaso K; Nakashima K
    J Neurosci Res; 2006 Nov; 84(6):1376-84. PubMed ID: 16917840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exposure to mixtures of endosulfan and zineb induces apoptotic and necrotic cell death in SH-SY5Y neuroblastoma cells, in vitro.
    Jia Z; Misra HP
    J Appl Toxicol; 2007; 27(5):434-46. PubMed ID: 17309119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease.
    Offen D; Sherki Y; Melamed E; Fridkin M; Brenneman DE; Gozes I
    Brain Res; 2000 Jan; 854(1-2):257-62. PubMed ID: 10784133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salsolinol, a dopamine-derived tetrahydroisoquinoline, induces cell death by causing oxidative stress in dopaminergic SH-SY5Y cells, and the said effect is attenuated by metallothionein.
    Wanpen S; Govitrapong P; Shavali S; Sangchot P; Ebadi M
    Brain Res; 2004 Apr; 1005(1-2):67-76. PubMed ID: 15044066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cx43 Mediates Resistance against MPP⁺-Induced Apoptosis in SH-SY5Y Neuroblastoma Cells via Modulating the Mitochondrial Apoptosis Pathway.
    Kim IS; Ganesan P; Choi DK
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27809287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A newly discovered neurotoxin ADTIQ associated with hyperglycemia and Parkinson's disease.
    Xie B; Lin F; Ullah K; Peng L; Ding W; Dai R; Qing H; Deng Y
    Biochem Biophys Res Commun; 2015 Apr; 459(3):361-6. PubMed ID: 25744031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, is mediated by activation of caspase 3.
    Akao Y; Nakagawa Y; Maruyama W; Takahashi T; Naoi M
    Neurosci Lett; 1999 Jun; 267(3):153-6. PubMed ID: 10380999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cells.
    Tasaki Y; Omura T; Yamada T; Ohkubo T; Suno M; Iida S; Sakaguchi T; Asari M; Shimizu K; Matsubara K
    Brain Res; 2010 Jul; 1344():25-33. PubMed ID: 20452332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells.
    Nakaso K; Ito S; Nakashima K
    Neurosci Lett; 2008 Feb; 432(2):146-50. PubMed ID: 18201823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
    Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F
    Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylpyridinium (MPP(+))- and nerve growth factor-induced changes in pro- and anti-apoptotic signaling pathways in SH-SY5Y neuroblastoma cells.
    Halvorsen EM; Dennis J; Keeney P; Sturgill TW; Tuttle JB; Bennett JB
    Brain Res; 2002 Oct; 952(1):98-110. PubMed ID: 12363409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type B monoamine oxidase and neurotoxins.
    Naoi M; Maruyama W
    Eur Neurol; 1993; 33 Suppl 1():31-7. PubMed ID: 8375430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.